Danavorexton
Danavorexton is a pharmaceutical drug that acts as an orexin receptor antagonist. It is primarily used in the treatment of sleep disorders, particularly narcolepsy. Danavorexton works by blocking the action of orexin, a neuropeptide that regulates arousal, wakefulness, and appetite.
Mechanism of Action[edit | edit source]
Danavorexton functions by inhibiting the binding of orexin to its receptors, specifically orexin receptor 1 (OX1R) and orexin receptor 2 (OX2R). Orexin, also known as hypocretin, is produced in the hypothalamus and plays a crucial role in maintaining wakefulness and regulating the sleep-wake cycle. By blocking orexin receptors, Danavorexton reduces the stimulatory effects of orexin, thereby promoting sleep.
Clinical Uses[edit | edit source]
Danavorexton is primarily indicated for the treatment of narcolepsy, a chronic sleep disorder characterized by excessive daytime sleepiness and sudden episodes of muscle weakness (cataplexy). It may also be used off-label for other sleep disorders, such as insomnia and sleep apnea, although its efficacy and safety for these conditions are still under investigation.
Side Effects[edit | edit source]
Common side effects of Danavorexton include:
Serious side effects are rare but may include:
- Severe allergic reactions
- Depression
- Suicidal thoughts
Contraindications[edit | edit source]
Danavorexton is contraindicated in individuals with a history of severe allergic reactions to the drug or any of its components. It should be used with caution in patients with a history of depression or other psychiatric disorders.
Pharmacokinetics[edit | edit source]
Danavorexton is administered orally and is absorbed through the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily through the urine. The drug has a half-life of approximately 12 hours, allowing for once-daily dosing.
Research and Development[edit | edit source]
Danavorexton is currently undergoing clinical trials to evaluate its efficacy and safety in a broader range of sleep disorders. Preliminary results suggest that it may be a promising treatment option for patients who do not respond to traditional therapies.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD